1 Study Coverage 1.1 Diabetes Devices and Drugs Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Introduction 1.2 Global Diabetes Devices and Drugs Outlook 2017 VS 2022 VS 2028 1.2.1 Global Diabetes Devices and Drugs Market Size for the Year 2017-2028 1.2.2 Global Diabetes Devices and Drugs Market Size for the Year 2017-2028 1.3 Diabetes Devices and Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Diabetes Devices and Drugs in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Diabetes Devices and Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Diabetes Devices and Drugs Market Dynamics 1.4.1 Diabetes Devices and Drugs Industry Trends 1.4.2 Diabetes Devices and Drugs Market Drivers 1.4.3 Diabetes Devices and Drugs Market Challenges 1.4.4 Diabetes Devices and Drugs Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Diabetes Devices and Drugs by Type 2.1 Diabetes Devices and Drugs Market Segment by Type 2.1.1 Diabetes Devices 2.1.2 Diabetes Drugs 2.2 Global Diabetes Devices and Drugs Market Size by Type (2017, 2022 & 2028) 2.3 Global Diabetes Devices and Drugs Market Size by Type (2017-2028) 2.4 United States Diabetes Devices and Drugs Market Size by Type (2017, 2022 & 2028) 2.5 United States Diabetes Devices and Drugs Market Size by Type (2017-2028) 3 Diabetes Devices and Drugs by Application 3.1 Diabetes Devices and Drugs Market Segment by Application 3.1.1 Diagnostic/Clinics 3.1.2 ICUs 3.1.3 Home Healthcare 3.2 Global Diabetes Devices and Drugs Market Size by Application (2017, 2022 & 2028) 3.3 Global Diabetes Devices and Drugs Market Size by Application (2017-2028) 3.4 United States Diabetes Devices and Drugs Market Size by Application (2017, 2022 & 2028) 3.5 United States Diabetes Devices and Drugs Market Size by Application (2017-2028) 4 Global Diabetes Devices and Drugs Competitor Landscape by Company 4.1 Global Diabetes Devices and Drugs Market Size by Company 4.1.1 Top Global Diabetes Devices and Drugs Companies Ranked by Revenue (2021) 4.1.2 Global Diabetes Devices and Drugs Revenue by Player (2017-2022) 4.2 Global Diabetes Devices and Drugs Concentration Ratio (CR) 4.2.1 Diabetes Devices and Drugs Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Diabetes Devices and Drugs in 2021 4.2.3 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Diabetes Devices and Drugs Headquarters, Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Type 4.3.1 Global Diabetes Devices and Drugs Headquarters and Area Served 4.3.2 Global Diabetes Devices and Drugs Companies Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Diabetes Devices and Drugs Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Diabetes Devices and Drugs Market Size by Company 4.5.1 Top Diabetes Devices and Drugs Players in United States, Ranked by Revenue (2021) 4.5.2 United States Diabetes Devices and Drugs Revenue by Players (2020, 2021 & 2022) 5 Global Diabetes Devices and Drugs Market Size by Region 5.1 Global Diabetes Devices and Drugs Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Diabetes Devices and Drugs Market Size by Region (2017-2028) 5.2.1 Global Diabetes Devices and Drugs Market Size by Region: 2017-2022 5.2.2 Global Diabetes Devices and Drugs Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Diabetes Devices and Drugs Market Size YoY Growth 2017-2028 6.1.2 North America Diabetes Devices and Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Diabetes Devices and Drugs Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Diabetes Devices and Drugs Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Diabetes Devices and Drugs Market Size YoY Growth 2017-2028 6.3.2 Europe Diabetes Devices and Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Diabetes Devices and Drugs Market Size YoY Growth 2017-2028 6.4.2 Latin America Diabetes Devices and Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Diabetes Devices and Drugs Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Diabetes Devices and Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Medtronic 7.1.1 Medtronic Company Details 7.1.2 Medtronic Business Overview 7.1.3 Medtronic Diabetes Devices and Drugs Introduction 7.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.1.5 Medtronic Recent Development 7.2 BD 7.2.1 BD Company Details 7.2.2 BD Business Overview 7.2.3 BD Diabetes Devices and Drugs Introduction 7.2.4 BD Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.2.5 BD Recent Development 7.3 Johnson & Johnson 7.3.1 Johnson & Johnson Company Details 7.3.2 Johnson & Johnson Business Overview 7.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction 7.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.3.5 Johnson & Johnson Recent Development 7.4 Abbott Laboratories 7.4.1 Abbott Laboratories Company Details 7.4.2 Abbott Laboratories Business Overview 7.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction 7.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.4.5 Abbott Laboratories Recent Development 7.5 Novo Nordisk 7.5.1 Novo Nordisk Company Details 7.5.2 Novo Nordisk Business Overview 7.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction 7.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.5.5 Novo Nordisk Recent Development 7.6 Bristol-Myers Squibb 7.6.1 Bristol-Myers Squibb Company Details 7.6.2 Bristol-Myers Squibb Business Overview 7.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction 7.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.6.5 Bristol-Myers Squibb Recent Development 7.7 DexCom 7.7.1 DexCom Company Details 7.7.2 DexCom Business Overview 7.7.3 DexCom Diabetes Devices and Drugs Introduction 7.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.7.5 DexCom Recent Development 7.8 Companion Medical 7.8.1 Companion Medical Company Details 7.8.2 Companion Medical Business Overview 7.8.3 Companion Medical Diabetes Devices and Drugs Introduction 7.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.8.5 Companion Medical Recent Development 7.9 GlaxoSmithKline 7.9.1 GlaxoSmithKline Company Details 7.9.2 GlaxoSmithKline Business Overview 7.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction 7.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.9.5 GlaxoSmithKline Recent Development 7.10 Glenmark Pharmaceuticals 7.10.1 Glenmark Pharmaceuticals Company Details 7.10.2 Glenmark Pharmaceuticals Business Overview 7.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction 7.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.10.5 Glenmark Pharmaceuticals Recent Development 7.11 Novartis 7.11.1 Novartis Company Details 7.11.2 Novartis Business Overview 7.11.3 Novartis Diabetes Devices and Drugs Introduction 7.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.11.5 Novartis Recent Development 7.12 Roche 7.12.1 Roche Company Details 7.12.2 Roche Business Overview 7.12.3 Roche Diabetes Devices and Drugs Introduction 7.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.12.5 Roche Recent Development 7.13 Sanofi 7.13.1 Sanofi Company Details 7.13.2 Sanofi Business Overview 7.13.3 Sanofi Diabetes Devices and Drugs Introduction 7.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.13.5 Sanofi Recent Development 7.14 MSD 7.14.1 MSD Company Details 7.14.2 MSD Business Overview 7.14.3 MSD Diabetes Devices and Drugs Introduction 7.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.14.5 MSD Recent Development 7.15 Astrazeneca 7.15.1 Astrazeneca Company Details 7.15.2 Astrazeneca Business Overview 7.15.3 Astrazeneca Diabetes Devices and Drugs Introduction 7.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.15.5 Astrazeneca Recent Development 7.16 Takeda 7.16.1 Takeda Company Details 7.16.2 Takeda Business Overview 7.16.3 Takeda Diabetes Devices and Drugs Introduction 7.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.16.5 Takeda Recent Development 7.17 North China Pharmaceutical Group Corporation 7.17.1 North China Pharmaceutical Group Corporation Company Details 7.17.2 North China Pharmaceutical Group Corporation Business Overview 7.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction 7.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.17.5 North China Pharmaceutical Group Corporation Recent Development 7.18 Huadong Medicine 7.18.1 Huadong Medicine Company Details 7.18.2 Huadong Medicine Business Overview 7.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction 7.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.18.5 Huadong Medicine Recent Development 7.19 Dongbao Pharmaceutical 7.19.1 Dongbao Pharmaceutical Company Details 7.19.2 Dongbao Pharmaceutical Business Overview 7.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction 7.19.4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.19.5 Dongbao Pharmaceutical Recent Development 7.20 Hisun Pharmacy 7.20.1 Hisun Pharmacy Company Details 7.20.2 Hisun Pharmacy Business Overview 7.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction 7.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.20.5 Hisun Pharmacy Recent Development 7.21 KELUN 7.21.1 KELUN Company Details 7.21.2 KELUN Business Overview 7.21.3 KELUN Diabetes Devices and Drugs Introduction 7.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.21.5 KELUN Recent Development 7.22 Ginwa 7.22.1 Ginwa Company Details 7.22.2 Ginwa Business Overview 7.22.3 Ginwa Diabetes Devices and Drugs Introduction 7.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.22.5 Ginwa Recent Development 7.23 Tianan Pharmaceutical 7.23.1 Tianan Pharmaceutical Company Details 7.23.2 Tianan Pharmaceutical Business Overview 7.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction 7.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2017-2022) 7.23.5 Tianan Pharmaceutical Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Diabetes Devices and Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Diabetes Devices and Drugs Market Trends Table 3. Diabetes Devices and Drugs Market Drivers Table 4. Diabetes Devices and Drugs Market Challenges Table 5. Diabetes Devices and Drugs Market Restraints Table 6. Global Diabetes Devices and Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Diabetes Devices and Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Diabetes Devices and Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Diabetes Devices and Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Diabetes Devices and Drugs Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Diabetes Devices and Drugs Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Diabetes Devices and Drugs Revenue Share by Player, 2017-2022 Table 13. Global Diabetes Devices and Drugs Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Diabetes Devices and Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Devices and Drugs as of 2021) Table 15. Top Players of Diabetes Devices and Drugs in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Diabetes Devices and Drugs Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Diabetes Devices and Drugs Players in United States Market, Ranking by Revenue (2021) Table 20. United States Diabetes Devices and Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Diabetes Devices and Drugs Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Diabetes Devices and Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Diabetes Devices and Drugs Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Diabetes Devices and Drugs Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Diabetes Devices and Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Diabetes Devices and Drugs Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Diabetes Devices and Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Diabetes Devices and Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Diabetes Devices and Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Medtronic Company Details Table 31. Medtronic Business Overview Table 32. Medtronic Diabetes Devices and Drugs Product Table 33. Medtronic Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 34. Medtronic Recent Development Table 35. BD Company Details Table 36. BD Business Overview Table 37. BD Diabetes Devices and Drugs Product Table 38. BD Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 39. BD Recent Development Table 40. Johnson & Johnson Company Details Table 41. Johnson & Johnson Business Overview Table 42. Johnson & Johnson Diabetes Devices and Drugs Product Table 43. Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 44. Johnson & Johnson Recent Development Table 45. Abbott Laboratories Company Details Table 46. Abbott Laboratories Business Overview Table 47. Abbott Laboratories Diabetes Devices and Drugs Product Table 48. Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 49. Abbott Laboratories Recent Development Table 50. Novo Nordisk Company Details Table 51. Novo Nordisk Business Overview Table 52. Novo Nordisk Diabetes Devices and Drugs Product Table 53. Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 54. Novo Nordisk Recent Development Table 55. Bristol-Myers Squibb Company Details Table 56. Bristol-Myers Squibb Business Overview Table 57. Bristol-Myers Squibb Diabetes Devices and Drugs Product Table 58. Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 59. Bristol-Myers Squibb Recent Development Table 60. DexCom Company Details Table 61. DexCom Business Overview Table 62. DexCom Diabetes Devices and Drugs Product Table 63. DexCom Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 64. DexCom Recent Development Table 65. Companion Medical Company Details Table 66. Companion Medical Business Overview Table 67. Companion Medical Diabetes Devices and Drugs Product Table 68. Companion Medical Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 69. Companion Medical Recent Development Table 70. GlaxoSmithKline Company Details Table 71. GlaxoSmithKline Business Overview Table 72. GlaxoSmithKline Diabetes Devices and Drugs Product Table 73. GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 74. GlaxoSmithKline Recent Development Table 75. Glenmark Pharmaceuticals Company Details Table 76. Glenmark Pharmaceuticals Business Overview Table 77. Glenmark Pharmaceuticals Diabetes Devices and Drugs Product Table 78. Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 79. Glenmark Pharmaceuticals Recent Development Table 80. Novartis Company Details Table 81. Novartis Business Overview Table 82. Novartis Diabetes Devices and Drugs Product Table 83. Novartis Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 84. Novartis Recent Development Table 85. Roche Company Details Table 86. Roche Business Overview Table 87. Roche Diabetes Devices and Drugs Product Table 88. Roche Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 89. Roche Recent Development Table 90. Sanofi Company Details Table 91. Sanofi Business Overview Table 92. Sanofi Diabetes Devices and Drugs Product Table 93. Sanofi Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 94. Sanofi Recent Development Table 95. MSD Company Details Table 96. MSD Business Overview Table 97. MSD Diabetes Devices and Drugs Product Table 98. MSD Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 99. MSD Recent Development Table 100. Astrazeneca Company Details Table 101. Astrazeneca Business Overview Table 102. Astrazeneca Diabetes Devices and Drugs Product Table 103. Astrazeneca Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 104. Astrazeneca Recent Development Table 105. Takeda Company Details Table 106. Takeda Business Overview Table 107. Takeda Diabetes Devices and Drugs Product Table 108. Takeda Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 109. Takeda Recent Development Table 110. North China Pharmaceutical Group Corporation Company Details Table 111. North China Pharmaceutical Group Corporation Business Overview Table 112. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Product Table 113. North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 114. North China Pharmaceutical Group Corporation Recent Development Table 115. Huadong Medicine Company Details Table 116. Huadong Medicine Business Overview Table 117. Huadong Medicine Diabetes Devices and Drugs Product Table 118. Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 119. Huadong Medicine Recent Development Table 120. Dongbao Pharmaceutical Company Details Table 121. Dongbao Pharmaceutical Business Overview Table 122. Dongbao Pharmaceutical Diabetes Devices and Drugs Product Table 123. Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 124. Dongbao Pharmaceutical Recent Development Table 125. Hisun Pharmacy Company Details Table 126. Hisun Pharmacy Business Overview Table 127. Hisun Pharmacy Diabetes Devices and Drugs Product Table 128. Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 129. Hisun Pharmacy Recent Development Table 130. KELUN Company Details Table 131. KELUN Business Overview Table 132. KELUN Diabetes Devices and Drugs Product Table 133. KELUN Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 134. KELUN Recent Development Table 135. Ginwa Company Details Table 136. Ginwa Business Overview Table 137. Ginwa Diabetes Devices and Drugs Product Table 138. Ginwa Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 139. Ginwa Recent Development Table 140. Tianan Pharmaceutical Company Details Table 141. Tianan Pharmaceutical Business Overview Table 142. Tianan Pharmaceutical Diabetes Devices and Drugs Product Table 143. Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2017-2022) & (US$ Million) Table 144. Tianan Pharmaceutical Recent Development Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Diabetes Devices and Drugs Product Picture Figure 2. Global Diabetes Devices and Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Diabetes Devices and Drugs Market Size 2017-2028 (US$ Million) Figure 4. United States Diabetes Devices and Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Diabetes Devices and Drugs Market Size 2017-2028 (US$ Million) Figure 6. United States Diabetes Devices and Drugs Market Share in Global 2017-2028 Figure 7. Diabetes Devices and Drugs Report Years Considered Figure 8. Product Picture of Diabetes Devices Figure 9. Product Picture of Diabetes Drugs Figure 10. Global Diabetes Devices and Drugs Market Share by Type in 2022 & 2028 Figure 11. Global Diabetes Devices and Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Diabetes Devices and Drugs Market Share by Type (2017-2028) Figure 13. United States Diabetes Devices and Drugs Market Share by Type in 2022 & 2028 Figure 14. United States Diabetes Devices and Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Diabetes Devices and Drugs Market Share by Type (2017-2028) Figure 16. Product Picture of Diagnostic/Clinics Figure 17. Product Picture of ICUs Figure 18. Product Picture of Home Healthcare Figure 19. Global Diabetes Devices and Drugs Market Share by Application in 2022 & 2028 Figure 20. Global Diabetes Devices and Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Diabetes Devices and Drugs Market Share by Application (2017-2028) Figure 22. United States Diabetes Devices and Drugs Market Share by Application in 2022 & 2028 Figure 23. United States Diabetes Devices and Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Diabetes Devices and Drugs Market Share by Application (2017-2028) Figure 25. North America Diabetes Devices and Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Diabetes Devices and Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Diabetes Devices and Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Diabetes Devices and Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Diabetes Devices and Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. UAE Diabetes Devices and Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Medtronic Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 54. BD Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 55. Johnson & Johnson Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 56. Abbott Laboratories Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 57. Novo Nordisk Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 59. DexCom Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 60. Companion Medical Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 61. GlaxoSmithKline Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 62. Glenmark Pharmaceuticals Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 63. Novartis Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 64. Roche Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 65. Sanofi Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 66. MSD Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 67. Astrazeneca Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 68. Takeda Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 69. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 70. Huadong Medicine Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 71. Dongbao Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 72. Hisun Pharmacy Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 73. KELUN Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 74. Ginwa Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 75. Tianan Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2017-2022) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Medtronic BD Johnson & Johnson Abbott Laboratories Novo Nordisk Bristol-Myers Squibb DexCom Companion Medical GlaxoSmithKline Glenmark Pharmaceuticals Novartis Roche Sanofi MSD Astrazeneca Takeda North China Pharmaceutical Group Corporation Huadong Medicine Dongbao Pharmaceutical Hisun Pharmacy KELUN Ginwa Tianan Pharmaceutical